A collagen-targeted protein MRI contrast agent developed at Georgia State University detected invasive lung tumors and ...

(Phys.org)—A new type of nanoparticle-based MRI contrast agent demonstrates selectivity for tumor cells over non-cancerous cells, can detect hypoxia, and is sensitive enough allow for the detection of ...

A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used ...

To enhance the visibility of organs as they are scanned with magnetic resonance imaging (MRI), patients are usually injected with a compound known as a contrast agent before going into the scanner.

Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...

CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient, and ...

Hello, I am Dr. Tansui.“I was told there is a shadow on my pancreas. Can a CT scan tell if it is cancer?”“I was told to get a contrast-enhanced CT, but is the contrast agent safe?”“If the CT scan says ...

Scientists discovered a safer MRI contrast agent for high-resolution 3D microvascular imaging. The new contrast agent offers a vast improvement over traditional gadolinium-based products. Heart attack ...

GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. Data from the first-in-human trial – presented at ...

NEW ORLEANS ― For patients with suspected coronary artery disease, the intravenous administration of a contrast agent during angiography is safer and faster than intra-arterial administration, a ...

Researchers have taken a key step forward in developing a new, possibly safer contrast agent for use in MRI exams. Researchers at Massachusetts General Hospital (MGH) have taken a key step forward in ...

A new way to detect liver cancer in its early stages uses a targeted MRI contrast agent that binds to proteins, researchers report. A study in Science Advances describes a newly identified biomarker ...